Abstract
Argentina Wound Care Management Medical Equipment Industry Report
Summary
This report is an essential source for in-depth information and data relating
to Argentina wound care management medical equipment market. It also offers
detailed and comprehensive coverage of market revenue, volume, distribution
and company share information; and latest news, financial deals and pipeline
products information of each of the key sub-segments of thewound care
management in Argentina
Scope
・ The report provides sector information broken down into detailed categories
and segments in country.
・ Total revenues, products sold, end users, and
average pricing.
・ Market shares of all the key competitors.
・ Key
pipeline products that are set to shape the market, broken down by sector.
・ Information on the top medical equipment companies in the sector in the
country covering business description, strategic analysis, and financial
information.
・ Healthcare structure, regulatory environment, approval
process, pricing trends and reimbursement.
・ Product and brand updates,
strategy changes, R&D projects, corporate expansions and contractions and
regulatory changes.
・ Key mergers and acquisitions, partnerships, private
equity investments and IPOs.
・ Customer, hospitals and physicians
data.
Reasons to buy
・ Gain a strong understanding of the industry at a global level, with break
downs for the country
・ Evaluate and compare the attractiveness of the
market in the country.
・ Identify growth segments and opportunities in
each industry sector within the country.
・ Evaluate the pipeline of key
products that will change the sector, and identify threats and opportunities
before the products are launched in the country.
・ Analyze the
competitiveness of the market in the country and identify hotspots.
・
Develop strategies based on the latest product, brand, expansion and research
and development news in the country.
・ Do deals with an understanding of
how competitors are financed, and the mergers and partnerships that have
shaped the market in the country.
・ Identify and analyze the strengths and
weaknesses of the industry incumbents in the country.
Table of Contents
Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 15
2.1 What Is This Report
About? 15
2.2 Definitions 15
2.2.1 Wound Care Management 15
3
Healthcare Sector Review 17
4 Wound Care Management in Argentina 19
4.1 Wound Care Management Overall Revenues (2000-2012) 19
4.2 Wound Care
Management Overall Volume (2000-2012) 25
4.3 Wound Care Management Overall
Company Shares (2005-2006) 28
5 Wound Closure Devices in Argentina 29
5.1 Wound Closure Devices Overall Revenues (2000-2012) 29
5.1.1 Skin
Closure Devices Overall Revenues (2000-2012) 33
5.1.2 Hemostats Overall
Revenues (2000-2012) 35
5.1.3 Tissue Sealants Overall Revenues (2000-2012)
37
5.2 Wound Closure Devices Overall Volume (2000-2012) 39
5.2.1 Skin
Closure Devices Overall Volume (2000-2012) 41
5.2.2 Hemostats Overall
Volume (2000-2012) 43
5.2.3 Tissue Sealants Overall Volume (2000-2012)
45
5.3 Wound Closure Devices Average Price (2000-2012) 47
5.3.1
Hemostats Average Price (2000-2012) 47
5.3.2 Tissue Sealants Average Price
(2000-2012) 49
5.3.3 Skin Closure Devices Average Price (2000-2012) 51
5.4 Wound Closure Devices Distribution Share (2005-2006) 53
5.5 Wound
Closure Devices Company Share (2005-2006) 54
6 Ostomy in Argentina 55
6.1 Ostomy Overall Revenue (2000-2012) 55
6.2 Ostomy Overall Volume
(2000-2012) 57
6.3 Ostomy Average Price (2000-2012) 59
6.4 Ostomy
Distribution Share (2005-2006) 61
6.5 Ostomy Company Share (2005-2006)
62
7 Advanced Wound Management in Argentina 63
7.1 Advanced Wound
Management Overall Revenue (2000-2012) 63
7.2 Advanced Wound Management
Overall Volume (2000-2012) 65
7.3 Advanced Wound Management Average Price
(2000-2012) 67
7.4 Advanced Wound Management Distribution Share
(2005-2006) 69
7.5 Advanced Wound Management Company Share (2005-2006)
70
8 Traditional Wound Management in Argentina 71
8.1 Traditional
Wound Management Overall Revenue (2000-2012) 71
8.2 Traditional Wound
Management Overall Volume (2000-2012) 73
8.3 Traditional Wound Management
Average Price (2000-2012) 75
8.4 Traditional Wound Management Distribution
Share (2005-2006) 77
8.5 Traditional Wound Management Company Share
(2005-2006) 78
9 Compression Therapy in Argentina 79
9.1 Compression
Therapy Overall Revenue (2000-2012) 79
9.2 Compression Therapy Overall
Volume (2000-2012) 81
9.3 Compression Therapy Average Price (2000-2012)
83
9.4 Compression Therapy Distribution Share (2005-2006) 85
9.5
Compression Therapy Company Share (2005-2006) 86
10 Baxter International
Company Profile 87
10.1 Company Overview 87
10.2 Business Overview
87
10.2.1 BioScience 87
10.2.2 Medication Delivery 87
10.2.3 Renal
88
10.2.4 Products 88
10.2.5 History 89
10.3 Value Chain Analysis
92
10.3.1 Manufacturing 92
10.3.2 Product Development 92
10.3.3
Sales and Marketing 93
10.4 SWOT Analysis 94
10.4.1 Baxter
International Inc. Strengths 94
10.4.2 Baxter International Inc.
Weaknesses 95
10.4.3 Baxter International Inc. Opportunities 96
10.4.4
Baxter International Inc. Threats 96
10.5 Financial and Operational Review
97
10.6 Locations And Subsidiaries 99
10.7 Financial Deals Landscape
101
10.7.1 Baiyunshan And Baxter Form A Joint Venture In China 101
10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration
102
10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific
and Maverick Capital 104
10.7.4 B. Braun Acquires Renal Therapy Business
Of Baxter 106
10.7.5 Innovata signs a license agreement with Baxter
International 107
10.7.6 Kuros Biosurgery Signs An Agreement With Baxter
International 109
10.7.7 Gambro Signs An Agreement With Baxter 110
10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement 112
10.7.9
Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of
INTERCEPT Blood System 113
10.7.10 Baxter International And Kaketsuken
Enter Into Agreement 115
10.7.11 Baxter To Acquire 40% Stake In Shanghai
Baxter From Worldbest Treeful 116
10.8 0-Recent Developments 118
10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year
2007 118
10.8.2 Dec 18, 2007: Baxter Elects CFO 120
10.8.3 Nov 13,
2007: Baxter Declares Quarterly Dividend 120
10.8.4 Aug 01, 2007: Baxter
Elects New Board Director 121
10.8.5 Jul 31, 2007: Baxter Announces
Quarterly Dividend 121
10.8.6 Mar 13, 2007: Baxter Declares Additional
Share Repurchase Authorization 121
10.8.7 Feb 13, 2007: Baxter Announces
Quarterly Dividend 122
10.8.8 Nov 28, 2006: Baxter Announces Annual
Dividend 122
10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin
America 122
10.9 Baxter International Inc. Pipeline Products 123
10.9.1 Next-Generation Home Hemodialysis Machine 123
11 Covidien Ltd./Tyco
Healthcare Company Profile 125
11.1 Company Overview 125
11.2 Business
Overview 125
11.2.1 Imaging Solutions 125
11.2.2 Medical Devices
125
11.2.3 Medical Supplies 126
11.2.4 Pharmaceutical Products 127
11.2.5 Retail Products 127
11.2.6 Products 128
11.2.7 History 128
11.3 Value Chain Analysis 129
11.3.1 Manufacturing 130
11.3.2 Product
Development 130
11.3.3 Sales and Marketing 131
11.4 SWOT Analysis
131
11.4.1 Covidien Ltd./Tyco Healthcare Strengths 132
11.4.2 Covidien
Ltd./Tyco Healthcare Weaknesses 133
11.4.3 Covidien Ltd./Tyco Healthcare
Opportunities 134
11.4.4 Covidien Ltd./Tyco Healthcare Threats 134
11.5 Financial and Operational Review 135
11.5.1 Financial Statements
135
11.5.2 Financial Ratios 136
11.6 Locations And Subsidiaries
136
11.7 Financial Deals Landscape 138
11.7.1 Covidien Signs An
Agreement With Allergan 138
11.7.2 Covidien Acquires Scandius Biomedical
139
11.7.3 Covidien International Finance Completes Private Placement Of
$2,750 Million 140
11.7.4 Covidien And BioSynthema Enter Into Licensing
Agreement 142
11.7.5 Integra LifeSciences Acquires Assets Of Radionics
Division From Covidien 143
11.7.6 Covidien To Sell European Incontinence
Business 145
11.7.7 Covidien To Acquire Tissue Science Laboratories
147
11.8 Recent Developments 148
11.8.1 Mar 28, 2008: Covidien Spends
$760,000 Lobbying Federal Government In 2007 148
11.8.2 Mar 18, 2008:
Covidien Declares Quarterly Dividend 149
11.8.3 Feb 21, 2008: Covidien
Gests Favorable Decision In Patent Litigation Case 149
11.8.4 Feb 07,
2008: Covidien Declares Q1 Fiscal 2008 Results 149
11.8.5 Jan 15, 2008:
Covidien Declares Quarterly Dividend 151
11.8.6 Jan 10, 2008: Covidien To
Declare Q1 Fiscal 2008 Results 151
11.8.7 Dec 06, 2007: Covidien Reports
Q4 Fiscal 2007 Results 151
11.8.8 Oct 04, 2007: Covidien And NewSouth
Innovations Collaborate To Develop Novel Imaging Agent 153
11.8.9 Sep
28, 2007: Covidien Declares Quarterly Dividend 153
11.8.10 Aug 09, 2007:
Covidien Declares Q3 Fiscal 2007 Results 153
11.9 Covidien Ltd./Tyco
Healthcare Pipeline Products 155
11.9.1 PleuraSeal Lung Sealant System
155
11.9.2 Sandman Intro CPAP Device 156
12 3M Company Profile 158
12.1 Company Overview 158
12.2 Business Overview 158
12.2.1 Consumer
and Office 158
12.2.2 Display and Graphics 158
12.2.3 Electro and
Communications 159
12.2.4 Health Care 159
12.2.5 Industrial and
Transportation 160
12.2.6 Safety, Security and Protection Services 161
12.2.7 Products 161
12.3 Value Chain Analysis 163
12.3.1 Manufacturing
163
12.3.2 Product Development 164
12.3.3 Sales and Marketing 164
12.4 SWOT Analysis 165
12.4.1 3M Company Strengths 165
3M Company
Weaknesses 166
3M Company Opportunities 166
3M Company Threats 167
12.5 Financial and Operational Review 168
12.6 Locations And Subsidiaries
169
12.7 Financial Deals Landscape 171
12.7.1 3M Canada Acquires Les
Entreprises Solumed 171
12.7.2 3M Acquires Bondo 173
12.7.3 3M
Acquires Lingualcare 175
12.7.4 3M Acquires Abzil Industria E Comercio
176
12.7.5 3M Acquires Neo Plast 178
12.7.6 3M Acquires Assets Of DMS
Chile 180
12.7.7 3M Acquires Business Of Innovative Paper Technologies
182
12.7.8 3M Acquires Powell 184
12.7.9 Gen-Probe Signs An Agreement
With 3M Company 186
12.7.10 3M Acquires Acolyte Biomedica 188
12.7.11
3M Acquires Sealed Air Corp.' S Interest In Polymask Corp. 190
12.7.12 3M
Sells Its Pharmaceutical Business To Meda AB 192
12.7.13 3M Acquires
SoftMed Systems 194
12.7.14 3M Sells its Pharmaceuticals Business to
Graceway 196
12.7.15 Gen-Probe Signs An Agreement With 3M 198
12.7.16
3M Sells its Pharmaceutical Operations in the Asia Pacific Region to
Ironbridge Capital and Archer Capital 200
12.7.17 3M Acquires Biotrace
International 202
12.7.18 Ekahau Secures $16 Million In Additional Funding
204
12.7.19 3M Acquires Brontes Technologies 207
12.7.20 3M acquires
Nylonge Corp 209
12.7.21 3M Signs An Agreement With ClozeX Medical 211
12.7.22 3M Acquires OMNII Oral Pharmaceuticals 213
12.7.23 3M Sells
Pharmaceutical Operations In The United States To Graceway 215
12.7.24 3M
Sells Pharmaceutical Business In Europe To Meda AB 217
12.7.25 3M Sells
Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer
Capital 220
12.7.26 3M Acquires Accuspray Application Technologies Inc.
222
12.7.27 3M to acquire Rochford Thompson Equipment 224
12.7.28 3M
To Acquire Aearo Technologies From Permira 226
12.7.29 Permira To Sell
Aearo Technologies To 3M 228
12.8 Recent Developments 231
12.8.1 Mar
31, 2008: HighJump Software Introduces Survey Management Solution for Direct
Store Delivery Businesses 231
12.8.2 Mar 24, 2008: Brazil' s Companhia de
Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line
Over Parana River in Sao Paulo State 231
12.8.3 Mar 19, 2008: 3M to
Headquarter Optical Systems Business in Asia 233
12.8.4 Mar 19, 2008: 3M
To Headquarter Optical Systems Business In North Asia 233
12.8.5 Feb 11,
2008: 3M Increases Dividend for the 50th Straight Year 233
12.8.6 Nov 12,
2007: 3M Declares Quarterly Dividend 233
12.8.7 Oct 24, 2007: 3M And Sanyo
Settle Suit On Lithium Ion Battery 233
12.8.8 Aug 13, 2007: 3M Declares
Quarterly Dividend 233
12.8.9 May 08, 2007: 3M Declares Quarterly Dividend
234
12.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid
Molecular Tests 234
13 Ethicon, Inc. Company Profile 235
13.1 Company
Overview 235
13.2 Business Overview 235
13.2.1 Products 236
13.3
Locations And Subsidiaries 236
13.4 Financial Deals Landscape 238
13.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON
238
13.4.2 Musculoskeletal Transplant Signs Marketing Agreement With
ETHICON 240
13.4.3 ETHICON Acquires Vascular Control Systems 241
13.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON
242
14 ConvaTec Company Profile 245
14.1 Company Overview 245
14.2
Business Overview 245
14.2.1 Major Products and Services 245
14.2.2
History 246
14.3 Locations And Subsidiaries 247
14.4 Recent
Developments 248
14.4.1 Jan 22, 2008: Vivolution Acquires Patent From BMS
248
14.4.2 Nov 12, 2007: Alltracel Signs Development Agreement With
ConvaTec 248
15 Regulation System 249
15.1 Documents Required 249
15.2 Labeling Requirements 250
16 Pricing and Reimbursement 251
17
Distribution Structure 252
18 APPENDIX 253
18.1 Global Markets Direct
Research Methodology 253
18.2 Coverage 254
18.3 Secondary Research
254
18.4 Primary Research 255
18.5 Models 255
18.6 Forecasts
256
18.7 Expert Panels 256
18.8 Currency Conversion 257
18.9
Contact Us 258
18.10 Disclaimer 258
List of Tables
1.1 List of Tables
Table 1: Wound Care Management, Argentina, Overall
Revenues ($ mn), 2000-2012 19
Table 2: Wound Care Management, Argentina,
Overall Revenues ($ mn), Historic, 2000-2007 20
Table 3: Wound Care
Management, Argentina, Overall Revenues ($ mn), Forecast, 2007-2012 21
Table 4: Wound Care Management, Argentina, Category Revenues ($ mn), 2000-2012
22
Table 5: Wound Care Management, Argentina, Category Revenues ($ mn),
Historic, 2000-2007 23
Table 6: Wound Care Management, Argentina, Category
Revenues ($ mn), Forecast, 2007-2012 24
Table 7: Wound Care Management,
Argentina, Category Volume (Units), 2000-2012 25
Table 8: Wound Care
Management, Argentina, Category Volume (Units), Historic, 2000-2007 26
Table 9: Wound Care Management, Argentina, Category Volume (Units), Forecast,
2007-2012 27
Table 10: Wound Care Management, Argentina, Overall Company
Share by Revenue ($ mn), 2005-2006 28
Table 11: Wound Closure Devices,
Argentina, Overall Revenues ($ mn), Historic, 2000-2007 29
Table 12: Wound
Closure Devices, Argentina, Overall Revenues ($ mn), Forecast, 2007-2012
30
Table 13: Wound Closure Devices, Argentina, Revenue by Segment ($ mn),
Historic, 2000-2007 31
Table 14: Wound Closure Devices, Argentina, Revenue
by Segment ($ mn), Forecast, 2007-2012 32
Table 15: Skin Closure Devices,
Argentina, Overall Revenues ($ mn), Historic, 2000-2007 33
Table 16: Skin
Closure Devices, Argentina, Overall Revenues ($ mn), Forecast, 2007-2012
34
Table 17: Hemostats, Argentina, Overall Revenues ($ mn), Historic,
2000-2007 35
Table 18: Hemostats, Argentina, Overall Revenues ($ mn),
Forecast, 2007-2012 36
Table 19: Tissue Sealants, Argentina, Overall
Revenues ($ mn), Historic, 2000-2007 37
Table 20: Tissue Sealants,
Argentina, Overall Revenues ($ mn), Forecast, 2007-2012 38
Table 21: Wound
Closure Devices, Argentina, Overall Volume (Units), Historic, 2000-2007 39
Table 22: Wound Closure Devices, Argentina, Overall Volume (Units), Forecast,
2007-2012 40
Table 23: Skin Closure Devices, Argentina, Overall Volume
(Units), Historic, 2000-2007 41
Table 24: Skin Closure Devices, Argentina,
Overall Volume (Units), Forecast, 2007-2012 42
Table 25: Hemostats,
Argentina, Overall Volume (Units), Historic, 2000-2007 43
Table 26:
Hemostats, Argentina, Overall Volume (Units), Forecast, 2007-2012 44
Table
27: Tissue Sealants, Argentina, Overall Volume (Units), Historic, 2000-2007
45
Table 28: Tissue Sealants, Argentina, Overall Volume (Units), Forecast,
2007-2012 46
Table 29: Hemostats, Argentina, Average Price ($), Historic,
2000-2007 47
Table 30: Hemostats, Argentina, Average Price ($), Forecast,
2007-2012 48
Table 31: Tissue Sealants, Argentina, Average Price ($),
Historic, 2000-2007 49
Table 32: Tissue Sealants, Argentina, Average Price
($), Forecast, 2007-2012 50
Table 33: Skin Closure Devices, Argentina,
Average Price ($), Historic, 2000-2007 51
Table 34: Skin Closure Devices,
Argentina, Average Price ($), Forecast, 2007-2012 52
Table 35: Wound
Closure Devices, Argentina, Distribution Share by Revenue ($ mn), 2005-2006
53
Table 36: Wound Closure Devices, Argentina, Company Share by Revenue ($
mn), 2005-2006 54
Table 37: Ostomy, Argentina, Overall Revenues ($ mn),
Historic, 2000-2007 55
Table 38: Ostomy, Argentina, Overall Revenues ($
mn), Forecast, 2007-2012 56
Table 39: Ostomy, Argentina, Overall Volume
(Units), Historic, 2000-2007 57
Table 40: Ostomy, Argentina, Overall
Volume (Units), Forecast, 2007-2012 58
Table 41: Ostomy, Argentina,
Average Price ($), Historic, 2000-2007 59
Table 42: Ostomy, Argentina,
Average Price ($), Forecast, 2007-2012 60
Table 43: Ostomy, Argentina,
Distribution Share by Revenue ($ mn), 2005-2006 61
Table 44: Ostomy,
Argentina, Company Share by Revenue ($ mn), 2005-2006 62
Table 45:
Advanced Wound Management, Argentina, Overall Revenues ($ mn), Historic,
2000-2007 63
Table 46: Advanced Wound Management, Argentina, Overall
Revenues ($ mn), Forecast, 2007-2012 64
Table 47: Advanced Wound
Management, Argentina, Overall Volume (Units), Historic, 2000-2007 65
Table 48: Advanced Wound Management, Argentina, Overall Volume (Units),
Forecast, 2007-2012 66
Table 49: Advanced Wound Management, Argentina,
Average Price ($), Historic, 2000-2007 67
Table 50: Advanced Wound
Management, Argentina, Average Price ($), Forecast, 2007-2012 68
Table 51:
Advanced Wound Management, Argentina, Distribution Share by Revenue ($ mn),
2005-2006 69
Table 52: Advanced Wound Management, Argentina, Company Share
by Revenue ($ mn), 2005-2006 70
Table 53: Traditional Wound Management,
Argentina, Overall Revenues ($ mn), Historic, 2000-2007 71
Table 54:
Traditional Wound Management, Argentina, Overall Revenues ($ mn), Forecast,
2007-2012 72
Table 55: Traditional Wound Management, Argentina, Overall
Volume (Units), Historic, 2000-2007 73
Table 56: Traditional Wound
Management, Argentina, Overall Volume (Units), Forecast, 2007-2012 74
Table 57: Traditional Wound Management, Argentina, Average Price ($),
Historic, 2000-2007 75
Table 58: Traditional Wound Management, Argentina,
Average Price ($), Forecast, 2007-2012 76
Table 59: Traditional Wound
Management, Argentina, Distribution Share by Revenue ($ mn), 2005-2006 77
Table 60: Traditional Wound Management, Argentina, Company Share by Revenue ($
mn), 2005-2006 78
Table 61: Compression Therapy, Argentina, Overall
Revenues ($ mn), Historic, 2000-2007 79
Table 62: Compression Therapy,
Argentina, Overall Revenues ($ mn), Forecast, 2007-2012 80
Table 63:
Compression Therapy, Argentina, Overall Volume (Units), Historic, 2000-2007
81
Table 64: Compression Therapy, Argentina, Overall Volume (Units),
Forecast, 2007-2012 82
Table 65: Compression Therapy, Argentina, Average
Price ($), Historic, 2000-2007 83
Table 66: Compression Therapy,
Argentina, Average Price ($), Forecast, 2007-2012 84
Table 67: Compression
Therapy, Argentina, Distribution Share by Revenue ($ mn), 2005-2006 85
Table 68: Compression Therapy, Argentina, Company Share by Revenue ($ mn),
2005-2006 86
Table 69: Baxter International Inc., SWOT Analysis, 2006
94
Table 70: Baxter International Inc., Financial Statements, USD
Million, 2002-2006 97
Table 71: Baxter International Inc., Financial
Ratios, USD Million, 2002-2006 98
Table 72: Baxter International
Inc., Other Locations 99
Table 73: Baxter International Inc.,
Subsidiaries 100
Table 74: Covidien Ltd./Tyco Healthcare, SWOT
Analysis, 2007 132
Table 75: Covidien Ltd./Tyco Healthcare, Financial
Statements, USD Million, 2003-2007 135
Table 76: Covidien Ltd./Tyco
Healthcare, Financial Ratios, USD Million, 2003-2007 136
Table 77:
Covidien Ltd./Tyco Healthcare, Other Locations 137
Table 78: Covidien
Ltd./Tyco Healthcare, Subsidiaries 137
Table 79: 3M Company, SWOT
Analysis, 2006 165
Table 80: 3M Company, Financial Statements, USD
Million, 2002-2006 168
Table 81: 3M Company, Financial and
Operational Overview, USD Million, 2002-2006(Contd.) 169
Table 82: 3M
Company, Subsidiaries 170
Table 83: Ethicon, Inc., Other Locations
237
Table 84: Ethicon, Inc., Subsidiaries 237
Table 85:
ConvaTec, Other Locations 247
Table 86: Currency Conversion from USD to
Local Currency at 2007 Constant Rate 257
List of
Figures
1.1 List of Figures
Figure 1: Healthcare System Financing
by Sources in Argentina, 2002 17
Figure 2: Wound Care Management,
Argentina, Overall Revenues ($ mn), 2000-2012 19
Figure 3: Wound Care
Management, Argentina, Overall Revenues ($ mn), Historic, 2000-2007 20
Figure 4: Wound Care Management, Argentina, Overall Revenues ($ mn), Forecast,
2007-2012 21
Figure 5: Wound Care Management, Argentina, Category Revenues
($ mn), 2000-2012 22
Figure 6: Wound Care Management, Argentina, Category
Revenues ($ mn), Historic, 2000-2007 23
Figure 7: Wound Care Management,
Argentina, Category Revenues ($ mn), Forecast, 2007-2012 24
Figure 8:
Wound Care Management, Argentina, Category Volume (Units), 2000-2012 25
Figure 9: Wound Care Management, Argentina, Category Volume (Units), Historic,
2000-2007 26
Figure 10: Wound Care Management, Argentina, Category Volume
(Units), Forecast, 2007-2012 27
Figure 11: Wound Care Management,
Argentina, Overall Company Share (%), 2006 28
Figure 12: Wound Closure
Devices, Argentina, Overall Revenues ($ mn), Historic, 2000-2007 29
Figure
13: Wound Closure Devices, Argentina, Overall Revenues ($ mn), Forecast,
2007-2012 30
Figure 14: Wound Closure Devices, Argentina, Revenue by
Segment ($ mn), Historic, 2000-2007 31
Figure 15: Wound Closure Devices,
Argentina, Revenue by Segment ($ mn), Forecast, 2007-2012 32
Figure 16:
Skin Closure Devices, Argentina, Overall Revenues ($ mn), Historic, 2000-2007
33
Figure 17: Skin Closure Devices, Argentina, Overall Revenues ($ mn),
Forecast, 2007-2012 34
Figure 18: Hemostats, Argentina, Overall Revenues
($ mn), Historic, 2000-2007 35
Figure 19: Hemostats, Argentina, Overall
Revenues ($ mn), Forecast, 2007-2012 36
Figure 20: Tissue Sealants,
Argentina, Overall Revenues ($ mn), Historic, 2000-2007 37
Figure 21:
Tissue Sealants, Argentina, Overall Revenues ($ mn), Forecast, 2007-2012
38
Figure 22: Wound Closure Devices, Argentina, Overall Volume (Units),
Historic, 2000-2007 39
Figure 23: Wound Closure Devices, Argentina,
Overall Volume (Units), Forecast, 2007-2012 40
Figure 24: Skin Closure
Devices, Argentina, Overall Volume (Units), Historic, 2000-2007 41
Figure
25: Skin Closure Devices, Argentina, Overall Volume (Units), Forecast,
2007-2012 42
Figure 26: Hemostats, Argentina, Overall Volume (Units),
Historic, 2000-2007 43
Figure 27: Hemostats, Argentina, Overall Volume
(Units), Forecast, 2007-2012 44
Figure 28: Tissue Sealants, Argentina,
Overall Volume (Units), Historic, 2000-2007 45
Figure 29: Tissue Sealants,
Argentina, Overall Volume (Units), Forecast, 2007-2012 46
Figure 30:
Hemostats, Argentina, Average Price ($), Historic, 2000-2007 47
Figure 31:
Hemostats, Argentina, Average Price ($), Forecast, 2007-2012 48
Figure 32:
Tissue Sealants, Argentina, Average Price ($), Historic, 2000-2007 49
Figure 33: Tissue Sealants, Argentina, Average Price ($), Forecast, 2007-2012
50
Figure 34: Skin Closure Devices, Argentina, Average Price ($),
Historic, 2000-2007 51
Figure 35: Skin Closure Devices, Argentina, Average
Price ($), Forecast, 2007-2012 52
Figure 36: Wound Closure Devices,
Argentina, Distribution Share (%), 2006 53
Figure 37: Wound Closure
Devices, Argentina, Company Share (%), 2006 54
Figure 38: Ostomy,
Argentina, Overall Revenues ($ mn), Historic, 2000-2007 55
Figure 39:
Ostomy, Argentina, Overall Revenues ($ mn), Forecast, 2007-2012 56
Figure
40: Ostomy, Argentina, Overall Volume (Units), Historic, 2000-2007 57
Figure 41: Ostomy, Argentina, Overall Volume (Units), Forecast, 2007-2012
58
Figure 42: Ostomy, Argentina, Average Price ($), Historic, 2000-2007
59
Figure 43: Ostomy, Argentina, Average Price ($), Forecast, 2007-2012
60
Figure 44: Ostomy, Argentina, Company Share (%), 2006 62
Figure 45:
Advanced Wound Management, Argentina, Overall Revenues ($ mn), Historic,
2000-2007 63
Figure 46: Advanced Wound Management, Argentina, Overall
Revenues ($ mn), Forecast, 2007-2012 64
Figure 47: Advanced Wound
Management, Argentina, Overall Volume (Units), Historic, 2000-2007 65
Figure 48: Advanced Wound Management, Argentina, Overall Volume (Units),
Forecast, 2007-2012 66
Figure 49: Advanced Wound Management, Argentina,
Average Price ($), Historic, 2000-2007 67
Figure 50: Advanced Wound
Management, Argentina, Average Price ($), Forecast, 2007-2012 68
Figure
51: Advanced Wound Management, Argentina, Distribution Share (%), 2006 69
Figure 52: Advanced Wound Management, Argentina, Company Share (%), 2006
70
Figure 53: Traditional Wound Management, Argentina, Overall Revenues ($
mn), Historic, 2000-2007 71
Figure 54: Traditional Wound Management,
Argentina, Overall Revenues ($ mn), Forecast, 2007-2012 72
Figure 55:
Traditional Wound Management, Argentina, Overall Volume (Units), Historic,
2000-2007 73
Figure 56: Traditional Wound Management, Argentina, Overall
Volume (Units), Forecast, 2007-2012 74
Figure 57: Traditional Wound
Management, Argentina, Average Price ($), Historic, 2000-2007 75
Figure
58: Traditional Wound Management, Argentina, Average Price ($), Forecast,
2007-2012 76
Figure 59: Traditional Wound Management, Argentina,
Distribution Share (%), 2006 77
Figure 60: Traditional Wound Management,
Argentina, Company Share (%), 2006 78
Figure 61: Compression Therapy,
Argentina, Overall Revenues ($ mn), Historic, 2000-2007 79
Figure 62:
Compression Therapy, Argentina, Overall Revenues ($ mn), Forecast, 2007-2012
80
Figure 63: Compression Therapy, Argentina, Overall Volume (Units),
Historic, 2000-2007 81
Figure 64: Compression Therapy, Argentina, Overall
Volume (Units), Forecast, 2007-2012 82
Figure 65: Compression Therapy,
Argentina, Average Price ($), Historic, 2000-2007 83
Figure 66:
Compression Therapy, Argentina, Average Price ($), Forecast, 2007-2012 84
Figure 67: Compression Therapy, Argentina, Distribution Share (%), 2006 85
Figure 68: Compression Therapy, Argentina, Company Share (%), 2006 86
Figure 69: Baxter International Inc., Value Chain Analysis 92
Figure
70: Covidien Ltd./Tyco Healthcare, Value Chain Analysis 129
Figure
71: 3M Company, Value Chain Analysis 163
Figure 72: Global Markets
Direct Methodology 253
